[
  {
    "text": "1.\n              Krieg AM (2007) Antiinfective applications of toll-like receptor 9 agonists. Proc Am Thorac Soc 4: 289\u201394.\n        doi:\n        10.1513/pats.200701-021AW.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "2.\n              Abreu MT, Fukata M, Arditi M (2005) TLR signaling in the gut in health and disease. J Immunol 174: 4453\u201360. \n                      Find this article online\n                    "
  }, 
  {
    "text": "3.\n              Sommariva M, De Cecco L, De Cesare M, Sfondrini L, M\u00e9nard S, et al. (2011) TLR9-agonists oppositely modulate DNA-repair genes in tumor vesus immune cells and ehance chemotherapy effects. Cancer Res 71: 6382\u201390. \n                      Find this article online\n                    "
  }, 
  {
    "text": "4.\n              De Cesare M, Calcaterra C, Pratesi G, Gatti L, Zunino F, et al. (2008) Eradication of ovarian tumor xenografts by locoregional administration of targeted immunotherapy. Clin Cancer Res 14: 5512\u20138.\n        doi:\n        10.1158/1078-0432.CCR-08-0445.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "5.\n              Filipowicz W, Bhattacharyya SN, Sonenberg N (2008) Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9: 102\u201314.\n        doi:\n        10.1038/nrg2290.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "6.\n              Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136: 215\u201333.\n        doi:\n        10.1016/j.cell.2009.01.002.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "7.\n              Griffiths-Jones S, Saini HK, van DS, Enright AJ (2008) miRBase: tools for microRNA genomics. Nucleic Acids Res 36: D154\u2013D158.\n        doi:\n        10.1093/nar/gkm952.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "8.\n              Griffiths-Jones S, Grocock RJ, van DS, Bateman A, Enright AJ (2006) miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34: D140\u2013D144.\n        doi:\n        10.1093/nar/gkj112.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "9.\n              Griffiths-Jones S (2004) The microRNA Registry. Nucleic Acids Res 32: D109\u2013D111.\n        doi:\n        10.1093/nar/gkh023.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "10.\n              Hermeking H (2012) MicroRNAs in the p53 network: micromanagement of tumour suppression. Nat Rev Cancer 12: 613\u201326.\n        doi:\n        10.1038/nrc3318.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "11.\n              Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, et al. (2008) Widespread changes in protein synthesis induced by microRNAs. Nature 455: 58\u201363.\n        doi:\n        10.1038/nature07228.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "12.\n              Wu S, Huang S, Ding J, Zhao Y, Liang L, et al. (2010) Multiple microRNAs modulate p21Cip1/Waf1 expression by directly targeting its 3\u2032 untranslated region. Oncogene 29: 2302\u20138.\n        doi:\n        10.1038/onc.2010.34.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "13.\n              Allen KE, Weiss GJ (2010) Resistance may not be futile: microRNA biomarkers for chemoresistance and potential therapeutics. Mol Cancer Ther 9: 3126\u201336.\n        doi:\n        10.1158/1535-7163.MCT-10-0397.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "14.\n              Landau DA, Slack FJ (2011) MicroRNAs in mutagenesis, genomic instability, and DNA repair. Semin Oncol 38: 743\u201351.\n        doi:\n        10.1053/j.seminoncol.2011.08.003.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "15.\n              Hu H, Gatti RA (2011) MicroRNAs: new players in the DNA damage response. J Mol Cell Biol 3: 151\u20138.\n        doi:\n        10.1093/jmcb/mjq042.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "16.\n              Sommariva M, De Cecco L, Tagliabue E, Balsari A (2012) Modulation of DNA repair genes induced by TLR9 agonists. A strategy to elimate \u201caltered\u201d cells? OncoImmunology 1: 258\u20139. \n                      Find this article online\n                    "
  }, 
  {
    "text": "17.\n              Benard J, Da Silva J, De Blois MC, Boyer P, Duvillard P, et al. (1985) Characterization of a human ovarian adenocarcinoma line, IGROV1, in tissue culture and in nude mice. Cancer Res 45: 4970\u20139. \n                      Find this article online\n                    "
  }, 
  {
    "text": "18.\n              Wright GW, Simon RM (2003) A random variance model for detection of differential gene expression in small microarray experiments. Bioinformatics 19: 2448\u201355.\n        doi:\n        10.1093/bioinformatics/btg345.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "19.\n              Sales G, Coppe A, Bisognin A, Biasiolo M, Bortoluzzi S, et al. (2010) MAGIA, a web-based tool for miRNA and Genes Integrated Analysis. Nucleic Acids Res 38: W352\u2013W359.\n        doi:\n        10.1093/nar/gkq423.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "20.\n              Shih KK, Qin LX, Tanner EJ, Zhou Q, Bisogna M, et al. (2011) A microRNA survival signature (MiSS) for advanced ovarian cancer. Gynecol Oncol 121: 444\u201350.\n        doi:\n        10.1016/j.ygyno.2011.01.025.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "21.\n              Bagnoli M, De CL, Granata A, Nicoletti R, Marchesi E, et al. (2011) Identification of a chrXq27.3 microRNA cluster associated with early relapse in advanced stage ovarian cancer patients. Oncotarget 2: 1265\u201378. \n                      Find this article online\n                    "
  }, 
  {
    "text": "22.\n              Johnson WE, Li C, Rabinovic A (2007) Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8: 118\u201327.\n        doi:\n        10.1093/biostatistics/kxj037.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "23.\n              Dolezalova D, Mraz M, Barta T, Plevova K, Vinarsky V, et al. (2012) MicroRNAs regulate p21(Waf1/Cip1) protein expression and the DNA damage response in human embryonic stem cells. Stem Cells 30: 1362\u201372. \n                      Find this article online\n                    "
  }, 
  {
    "text": "24.\n              Berezikov E, Thuemmler F, van Laake LW, Kondova I, Bontrop R, et al. (2006) Diversity of microRNAs in human and chimpanzee brain. Nat Genet 38: 1375\u20137.\n        doi:\n        10.1038/ng1914.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "25.\n              Nam EJ, Yoon H, Kim SW, Kim H, Kim YT, et al. (2008) MicroRNA expression profiles in serous ovarian carcinoma. Clin Cancer Res 14: 2690\u20135.\n        doi:\n        10.1158/1078-0432.CCR-07-1731.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "26.\n              Kim TH, Kim YK, Kwon Y, Heo JH, Kang H, et al. (2010) Deregulation of miR-519a, 153, and 485\u20135p and its clinicopathological relevance in ovarian epithelial tumours. Histopathology 57: 734\u201343.\n        doi:\n        10.1111/j.1365-2559.2010.03686.x.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "27.\n              Stronach EA, Alfraidi A, Rama N, Datler C, Studd JB, et al. (2011) HDAC4-regulated STAT1 activation mediates platinum resistance in ovarian cancer. Cancer Res 71: 4412\u201322.\n        doi:\n        10.1158/0008-5472.CAN-10-4111.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "28.\n              Baltimore D, Boldin MP, O\u2019Connell RM, Rao DS, Taganov KD (2008) MicroRNAs: new regulators of immune cell development and function. Nat Immunol 9: 839\u201345.\n        doi:\n        10.1038/ni.f.209.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "29.\n              Lodish HF, Zhou B, Liu G, Chen CZ (2008) Micromanagement of the immune system by microRNAs. Nat Rev Immunol 8: 120\u201330. \n                      Find this article online\n                    "
  }, 
  {
    "text": "30.\n              O\u2019Connell RM, Rao DS, Chaudhuri AA, Baltimore D (2010) Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol 10: 111\u201322.\n        doi:\n        10.1038/nri2708.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "31.\n              Nahid MA, Satoh M, Chan EK (2011) MicroRNA in TLR signaling and endotoxin tolerance. Cell Mol Immunol 8: 388\u2013403.\n        doi:\n        10.1038/cmi.2011.26.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "32.\n              Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, et al. (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9: 654\u20139.\n        doi:\n        10.1038/ncb1596.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "33.\n              Jin KL, Park JY, Noh EJ, Hoe KL, Lee JH, et al. (2010) The effect of combined treatment with cisplatin and histone deacetylase inhibitors on HeLa cells. J Gynecol Oncol 21: 262\u20138.\n        doi:\n        10.3802/jgo.2010.21.4.262.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "34.\n              Ozaki K, Kishikawa F, Tanaka M, Sakamoto T, Tanimura S, et al. (2008) Histone deacetylase inhibitors enhance the chemosensitivity of tumor cells with cross-resistance to a wide range of DNA-damaging drugs. Cancer Sci 99: 376\u201384.\n        doi:\n        10.1111/j.1349-7006.2007.00669.x.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "35.\n              Stiborova M, Eckschlager T, Poljakova J, Hrabeta J, Adam V, et al.. (2012) The synergistic effects of DNA-targeted chemotherapeutics and histone deacetylase inhibitors as therapeutic strategies for cancer treatment. Curr Med Chem. "
  }, 
  {
    "text": "36.\n              Thurn KT, Thomas S, Moore A, Munster PN (2011) Rational therapeutic combinations with histone deacetylase inhibitors for the treatment of cancer. Future Oncol 7: 263\u201383.\n        doi:\n        10.2217/fon.11.2.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "37.\n              Gryder BE, Sodji QH, Oyelere AK (2012) Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed. Future Med Chem 4: 505\u201324.\n        doi:\n        10.4155/fmc.12.3.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "38.\n              Miska EA (2005) How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev 15: 563\u20138.\n        doi:\n        10.1016/j.gde.2005.08.005.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "39.\n              Jackson AL, Levin AA (2012) Developing microRNA Therapeutics: Approaching the Unique Complexities. Nucleic Acid Ther 22: 213\u201325. \n                      Find this article online\n                    "
  }
]